share_log

Needham Reiterates Buy on Trevi Therapeutics, Maintains $8 Price Target

Needham Reiterates Buy on Trevi Therapeutics, Maintains $8 Price Target

Needham重申买入Trevi Therapeutics,维持8美元的目标股价
Moomoo 24/7 ·  03/21 06:53

Needham analyst Serge Belanger reiterates Trevi Therapeutics (NASDAQ:TRVI) with a Buy and maintains $8 price target.

Needham分析师塞尔吉·贝兰格重申Trevi Therapeutics(纳斯达克股票代码:TRVI)的买入并维持8美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发